The peripheral-type benzodiazepine receptor or recognition site (PBR) is a widely distributed
transmembrane protein that is located mainly in the outer mitochondrial membrane. The …

Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms
of neurodegeneration in Alzheimer's disease (AD) and related tauopathies. Here, we have …

The use of photothermal agents (PTAs) in cancer photothermal therapy (PTT) has shown
promising results in clinical studies. The rapid degradation of PTAs may address safety …

Peptide-based materials that have diverse structures and functionalities are an important type
of biomaterials. In former times, peptide-based nanomaterials with excellent stability were …

A panel of radiochemicals has enabled in vivo positron emission tomography (PET) of tau
pathologies in Alzheimer's disease (AD), although sensitive detection of frontotemporal lobar …

Diverse neurodegenerative disorders are characterized by deposition of tau fibrils composed
of conformers (ie strains) unique to each illness. The development of tau imaging agents …

The chemogenetic technology designer receptors exclusively activated by designer drugs (DREADDs)
afford remotely reversible control of cellular signaling, neuronal activity and …

We demonstrate the significance of peripheral benzodiazepine receptor (PBR) imaging in
living mouse models of Alzheimer's disease (AD) as biomarkers and functional signatures of …

… Author links open overlay panel Lingling Zhang a b † , Kuan Hu c † , Tuo Shao d , Lu
Hou a , Shaojuan Zhang a , Weijian Ye a , Lee Josephson d , Jeffrey H. Meyer e , Ming-Rong …

Boron neutron capture therapy (BNCT) is a potential cancer radiotherapeutic modality, which
takes advantage of the neutron capture response that occurs when boron ( 10 B) is struck …